WELCOME TO JOHNS HOPKINS HEALTH ALERTS!

This free public service from Johns Hopkins Medicine helps keep you up to date on the latest breakthroughs for the most common medical conditions which prevent healthy aging. Browse all the articles via the Health Alert Topics navigation bar on the right, or read the headlines below.


Get the latest news sent straight to your Inbox. Register now for your FREE Johns Hopkins Health Alerts. Check the boxes below for all the topics you are interested in, enter your email address, and click "Send." It's fast, easy, and FREE.   Benefits of Being A Registered User

Enter your email here: (Example: yourname@domain.com)
Please send my alerts as:

We value your privacy and will never rent your email address.Already a Member? Manage your Health Alerts


Johns Hopkins Health Alert

Dry Eye Research Update

Comments (2)

  • Autologous serum eye drops – promising therapy for dry eye

 

Autologous serum eye drops, which are derived from a person’s own blood, are gaining ground as a potential treatment for severe dry eye disease that doesn’t respond to conventional treatment. Japanese researchers divided a group of 20 people with severe dry eye disease into two subsets. One group of dry eye patients used only preservative-free artificial tears and the second group of dry eye patients used only autologous serum eye drops for two weeks of treatment. At the end of the treatment period, those who had used the autologous eye drops showed significant improvement of dry eye on several clinical measures of the health of the eye’s surface and reported greater improvement on subjective measures of comfort.

Autologous serum eye drops, contain essential tear components, such as vitamin A and several growth factors. They have been found to be beneficial in treating several eye surface diseases, in addition to dry eye. As for their use in treating dry eye, the researchers say that the next step is to evaluate a larger group of patients over a longer treatment period. This research was reported in the American Journal of Ophthalmology, Volume 139, page. 242.

  • The connection between dry eye and diabetes

 

People with diabetes, especially those with poor glycemic control, are more likely than non-diabetic patients to have dry eye, according to an article in the American Journal of Ophthalmology, Volume 139, page 498. Researchers followed the medical records of 159,624 people who belonged to an Israeli HMO for one year. All of the participants were older than age 50, and 22,382 had diabetes. The researchers tracked the use of artificial tears among the patients with diabetes and those who did not have the disorder. At the end of the year, 20.6% of the patients with diabetes and 13.8% of those without diabetes had used artificial tears.

Moreover, the researchers found a clear trend of greater use of artificial tears as glycemic control (measured by levels of HbA1c) declined. The researchers note that dry eye in people with diabetes may be due in part to damage to the microvasculature of the lacrimal gland (which secretes tears) in the eye. Sensory neuropathy (a nerve disorder) in the cornea also may play a role, as may side effects of medications used to control diabetes.

Posted in Vision on June 29, 2007
Reviewed September 2011


Medical Disclaimer: This information is not intended to substitute for the advice of a physician. Click here for additional information: Johns Hopkins Health Alerts Disclaimer


Notify Me

Would you like us to inform you when we post new Vision Health Alerts?

Post a Comment

Comments

Health Alerts registered users may post comments and share experiences here at their own discretion. We regret that questions on individual health concerns to the Johns Hopkins editors cannot be answered in this space.

The views expressed here do not constitute medical advice, and do not represent the position of Johns Hopkins Medicine or Remedy Health Media, LLC, which has no responsibility for any comments posted on this site.


I have had dry eyes for several years and have used hypotears, especially during the night. If I take two fish oil/flax seed oil capsules, my condition is greatly improved, and I do not have to use the drops. When I forget to take the supplement - even for one day - my eyes are dry, and I have to use drops.

Posted by: Judyz | March 17, 2009 7:05 PM

Neurapathy was caused in my legs due to infarction on the spine. Then after chemo for Coiin Cancer in 2007 it caused this in my hands.

Posted by: 4health | March 12, 2011 12:08 PM

Post a Comment


Already a subscriber?

Login

Forgot your password?

New to Johns Hopkins Health Alerts?

Register to submit your comments.

(example: yourname@domain.com)

(800) 829-0422

Registered Users Log-in:

Forgot Password?

Become a Registered User!
It's fast and FREE!
The Benefits of Being a Registered User

Health Topic Pages

  • Health Alert
  • Special Report

What is this?

XML


Johns Hopkins' Vision Bestsellers

Controlling Glaucoma to Prevent Vision Loss

Written by Harry A. Quigley, M.D., Director of the Dana Center for Preventive Ophthalmology at the acclaimed Wilmer Eye Institute at Johns Hopkins, Controlling Glaucoma to Prevent Vision Loss provides straightforward answers to your most important questions about managing glaucoma, a condition that affects an estimated 2.5 million Americans. Controlling Glaucoma to Prevent Vision Loss discusses everything you need to know about glaucoma: its possible causes, the current methods for diagnosing it, and the many options that you have to treat it, from eye drops to laser surgery. If you or a loved one has glaucoma, our new report will give you the information you need to make informed treatment decisions that could save your sight. Read more or order the INSTANT PDF DOWNLOAD

 


Johns Hopkins Vision White Paper 2011

2011 Vision White Paper
Written by Dr. Susan B. Bressler, professor of ophthalmology at the acclaimed Wilmer Eye Institute, and a team of top Johns Hopkins doctors, this comprehensive report is essential reading for anyone affected by a vision disorder, including low vision, cataracts, glaucoma, age-related macular degeneration, and diabetic retinopathy. 88 pages.
Read more or order the INSTANT PDF DOWNLOAD EDITION
Read more or order the PRINT EDITION




Johns Hopkins Diabetes White Paper 2011


2011 Diabetes White Paper
The Diabetes White Paper teaches you how to manage Type 1 and Type 2 diabetes and avoid complications, such as nerve damage, heart disease, kidney failure, and retinopathy. This comprehensive report explains the basics of how your body metabolizes glucose and reviews the latest medications and tools for monitoring your blood glucose. Includes diagrams, glossary, and recent research. 96 pages.
Read more or order the INSTANT PDF DOWNLOAD EDITION
Read more or order the PRINT EDITION